The Influence of Kidney Function on Dapagliflozin Exposure, Metabolism and Pharmacodynamics in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.12056